Home › Familial Amyloid Neuropathies › New York
Familial Amyloid Neuropathies clinical trials in New York
6 studies for Familial Amyloid Neuropathies are looking for participants at sites in New York.
Cities in New York
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
- Research Site, Manhasset
- Research Site, New York
- Research Site, New York
- and 1 more
RecruitingObservational study
Ages 18 to 130 · All sexes · Updated Sep 23, 2026 · NCT06465810ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
- Clinical Trial Site, New York
RecruitingObservational study
All ages · All sexes · Updated Sep 8, 2026 · NCT04561518Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers
- Columbia University Medical Center, New York
RecruitingObservational study
Ages 30 to 80 · All sexes · Updated Aug 31, 2026 · NCT05489549Cardiovascular Multimodality Imaging Study
- Montefiore Health System, The Bronx
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT06610019Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- New York University (NYU) School of Medicine - Langone Medical Center, New York
- Mount Sinai Hospital, New York
- Columbia University Medical Center, New York
- and 1 more
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Aug 4, 2026 · NCT06563895Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis
- Columbia University Irving Medical Center, New York
RecruitingObservational studyHealthy volunteers welcome
Ages 50 and older · All sexes · Updated Jun 4, 2026 · NCT06034405From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.